ARA 290 vs DSIP
ARA 290 and DSIP are studied in overlapping research areas, which is why they are frequently compared. This is a neutral side-by-side reference drawn from published preclinical literature and laboratory handling data.
How they actually differ
Comparing the two: ARA 290 is 11-amino-acid epo-derived linear peptide, while DSIP is nonapeptide (9 residues), strongly acidic — different molecular classes with different handling consequences; they call for different primary diluents (bacteriostatic water (0.9% benzyl alcohol) versus sterile or bacteriostatic water); their leading degradation routes differ (asparagine/glutamine deamidation is the most plausible slow route for this sequence. for ARA 290, tryptophan photo-oxidation for DSIP), so the storage precautions that matter are not the same; their practical working windows differ once reconstituted. The sections below set out each in full.
ARA 290 — origin
ARA 290 (Cibinetide) is an 11-residue peptide modelled on the helix-B surface of erythropoietin. It was engineered to engage the innate repair receptor — a heteromer of the EPO receptor and the beta-common receptor — without the erythropoietic (red-blood-cell-stimulating) activity of full-length EPO.
DSIP — origin
DSIP was isolated in the 1970s from the cerebral venous blood of rabbits in slow-wave sleep, in one of the more unusual isolation efforts in neuropeptide research. The name records the assay it was found by rather than a settled mechanism — its physiological role remains debated in the literature.
ARA 290 research themes
Studied for selective engagement of the EPOR/beta-common receptor heteromer that mediates tissue-protective signalling, distinct from the classical erythropoietic receptor.
A substantial share of the published literature examines small-fibre and neuropathic-pain research models.
Investigated for modulation of inflammatory pathways in preclinical tissue-injury models.
DSIP research themes
Investigated for effects on slow-wave sleep in the models that gave the peptide its name.
Studies have examined interactions with stress-axis signalling.
Explored in preclinical models of oxidative and stress-related neuronal injury.
Notably, decades of work have not converged on an accepted receptor or mechanism — a recurring theme in the literature.
ARA 290 handling
- Reach room temperature before opening the vial.
- Add diluent gently down the vial wall; do not vortex.
- Use low-bind labware at low working concentrations to limit adsorption.
DSIP handling
- Store and handle protected from light at all stages, including during reconstitution.
- Keep working solutions at or above neutral pH; acidification risks precipitation near the isoelectric point.
- Avoid prolonged storage of reconstituted material — the isomerisation route is slow but cumulative.
Both third-party tested
Every Popular Peptides batch of ARA 290 and DSIP is independently tested by HPLC and LC-MS with a published Certificate of Analysis. Enter a lot number to pull the COA for a specific vial.
ARA 290 reference
Related comparisons
ARA 290 and DSIP are supplied strictly as research chemicals for in-vitro laboratory and research use only. They are not intended for human or animal consumption, diagnostic, or therapeutic use. This comparison summarizes published preclinical literature and laboratory handling data; it is not medical advice, not a claim of efficacy, and not usage guidance.